-
Food Allergy in IBS: Patch Testing; A Relationship Between Atrial Flutter and Sleep Apnea; Beyond Hypertension: Metabolic Effects of Telmisartan
-
A new combination of an inhaled corticosteriod and a long-acting beta2-adrenergic agonist has been approved for the treatment of chronic obstructive pulmonary disease (COPD).
-
Corticosteroid use is associated with an increased risk of symptomatic pulmonary embolism. The greatest risk is in the first 30 days of use and increases with increasing steroid dose.
-
-
This study reports an association between infection burden and dementia, although the relationship may not be causal.
-
Stepwise risk factor-stratified screening in an elderly population using a handheld ECG device detected a significant number of patients with silent paroxysmal atrial fibrillation.
-
Beta-blockers and noncardiac surgery; prenatal medication exposure and risk of autism; reasons for statin discontinuations; and FDA actions.
-
Colchicine, in addition to statins and other standard secondary prevention therapies, appeared effective for the prevention of cardiovascular events in patients with stable coronary disease.
-
As a federal program rolls out to award providers with incentives for achieving meaningful use in electronic health records, wide measure-by-measure variation can jeopardize the validity of electronic reporting.
-
On January 14, 2013, the FDA approved a device allowing detection of multiple gastrointestinal pathogens from a single sample of feces.1
